IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Colorectal cancer is a leading cause of cancer-related deaths worldwide. Chronic inflammation is recognized as a predisposing factor for the development of colon cancer, but the molecular mechanisms linking inflammation and tumorigenesis have remained elusive. Recent studies revealed a crucial role for the NOD-like receptor protein Nlrp3 in regulating inflammation through the assembly of proinflammatory protein complexes termed inflammasomes. However, its role in colorectal tumor formation remains unclear. In this study, we showed that mice deficient for Nlrp3 or the inflammasome effector caspase-1 were highly susceptible to azoxymethane/dextran sodium sulfate-induced inflammation and suffered from dramatically increased tumor burdens in the colon. This was a consequence of markedly reduced IL-18 levels in mice lacking components of the Nlrp3 inflammasome, which led to impaired production and activation of the tumor suppressors IFN-γ and STAT1, respectively. Thus, IL-18 production downstream of the Nlrp3 inflammasome is critically involved in protection against colorectal tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [124]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [124]
Experimental — accuracy not yet measuredIn the citing paper
“In fact, IL-18 KO or IL-18R KO mice are also highly sensitive to colitis-associated CRC [124,125].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · cited 1×
“The synthesis and secretion of these cytokines is controlled by transcription factors of the STAT, NF-kB, and AP-1 families (6).”
BackgroundDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 1×
“in the NLR protein NOD2 are linked with the development of Crohn’s disease in humans (41, 42).”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 1×
“in the NLR protein NOD2 are linked with the development of Crohn’s disease in humans (41, 42).”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896 · cited 1×
“Indeed, IL-18 was originally identified as the “IFN-g–inducing factor” (22), and IFN-g has been described as a pleiotropic cytokine with potent antitumor activity (34, 37).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Cited by
Items 201–300 of 457
Mladenova, D. N., & Kohonen‐Corish, M. R. J. (2012) · PubMed · Cited by 38
Effector functions of NLRs in the intestine: innate sensing, cell death, and disease
Yeretssian, G. (2012) · Immunologic Research · doi:10.1007/s12026-012-8317-3 · Cited by 37
Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis
Wang, S., He, H., Qu, L., Shen, Q., & Dai, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1446486 · Cited by 38
The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases
Li, Y., Lin, X., Gao, S., Wang, W., Cheng, S., Wang, W., Huang, Y., 邹一丰, Zhu, R., Jia, K., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.926915 · Cited by 37
Induction of pyroptotic cell death as a potential tool for cancer treatment
Faria, S. S., Fernando, A. J., de Lima, V. C. C., Rossi, A. G., de Carvalho, J. M. A., & Magalhães, K. G. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00316-9 · Cited by 36
Chen, F., Wu, Y.-L., Cheng, C., Hsiao, Y., Chi, J.-Y., Hung, L., Chang, C., Lai, M., & Wang, J. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-023-00991-7 · Cited by 35
“In the antitumor role of pyroptosis, pyroptosis-induced inflammasome activation suppresses tumorigenesis in colitis-associated colon cancer [57–59].”
BackgroundMiR-223-3p attenuates the migration and invasion of NSCLC cells by regulating NLRP3
Zhu, S., Kong, X., Song, M., Chi, M., Liu, Y., Zhang, P., Zhang, Q., Shang, P., & Feng, F. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.985962 · Cited by 35
Chen, L., Wan, S., Mao, L., Huang, C., Bu, L., & Sun, Z. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03357-4 · Cited by 35
“For example, IL-18 maintains colonic epithelial homeostasis, plays a protective role in colitis-associated colon cancer [35], and enhances the killing activity of NK cells against liver metastases of colon cancer cells [36].”
BackgroundThe NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers
Gouravani, M., Khalili, N., Razi, S., Keshavarz‐Fathi, M., Khalili, N., & Rezaei, N. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1713755 · Cited by 35
“suggest that at the early stage of CAC, IL-18 can intensify colitis-induced proliferation while suppressing it in the late phase, exhibiting a biphasic role for IL-18 [73].”
BackgroundInfluentialIyer, K., Erkert, L., & Becker, C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1228283 · Cited by 34
Inflammasomes and Colorectal Cancer
Shahbaz, S. K., Koushki, K., Ayati, S. H., Bland, A. R., Bezsonov, E. E., & Sahebkar, A. (2021) · Cells · doi:10.3390/cells10092172 · Cited by 34
“Therefore, IL-18 signaling downstream of the NLRP3 inflammasome plays a central role in the protection against colorectal cancer progression [89].”
BackgroundResultFlood, B., Manils, J., Nulty, C., Flis, E., Kenealy, S., Barber, G. L., Fay, J., Mills, K. H. G., Kay, E. W., & Creagh, E. M. (2018) · Oncogene · doi:10.1038/s41388-018-0613-5 · Cited by 34
Raut, P. K., & Park, P. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114186 · Cited by 34
Semaphorin 3F and Netrin-1: The Novel Function as a Regulator of Tumor Microenvironment
Nakayama, H., Kusumoto, C., Nakahara, M., Fujiwara, A., & Higashiyama, S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01662 · Cited by 33
“It has been reported that NLRP3 mediates IL18 secretion to protect individuals from colitis-associated colorectal cancer (Allen et al., 2010; Zaki et al., 2010).”
BackgroundMónaco, A., Chilibroste, S., Yim, L., Chabalgoity, J. A., & Moreno, M. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03148-x · Cited by 35
“tective, through IFN-γ production [33].”
The Inflammasome: Regulation of Nitric Oxide and Antimicrobial Host Defence
Ramachandran, R. A., Lupfer, C. R., & Zaki, H. (2018) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2018.01.004 · Cited by 33
The role of pyroptosis in cancer: key components and therapeutic potential
Liu, Z., Xu, S., Chen, L., Gong, J., & Wang, M. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01932-z · Cited by 32
Privitera, G., Rana, N., Scaldaferri, F., Armuzzi, A., & Pizarro, T. T. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.806680 · Cited by 32
Djouina, M., Waxin, C., Caboche, S., Lecointe, K., Steimle, A., Beury, D., Desai, M. S., Hot, D., Dubuquoy, L., Launay, D., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165722 · Cited by 32
Self-citationPyroptosis: A possible link between obesity‐related inflammation and inflammatory diseases
Pan, M., Tai, R., Yanrong, L., Sun, Z., Yuan, H., Qiong, W., Yongnian, L., & Sun, C. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30627 · Cited by 31
Ringel-Scaia, V. M., McDaniel, D. K., & Allen, I. C. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2017019158 · Cited by 32
The Impact of the Gut Microbiome on Colorectal Cancer
Maisonneuve, C., Irrazábal, T., Martín, A., Girardin, S. E., & Philpott, D. J. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050240 · Cited by 31
“Deficiency for other members of the inflammasome or NLRs, including Nlrp3 and Nlrc4, has also been associated with CRC development, but their functional mechanisms in microbial-driven cancer remain elusive (Hu et al. 2010, Zaki et al. 2010).”
BackgroundInflammasomes in cancer: Effect of epigenetic and autophagic modulations
Mishra, S. R., Mahapatra, K. K., Behera, B. P., Bhol, C. S., Praharaj, P. P., Panigrahi, D. P., Patra, S., Singh, A., Patil, S., Dhiman, R., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.013 · Cited by 31
Wang, L., Hsu, C., Chen, C.-C., Liang, Y. J., Chen, L., Ojcius, D. M., Tsang, N., Hsueh, C., Wu, C., & Chang, Y. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.020594 · Cited by 31
Li, J., Qin, X., Shi, J., Wang, X., Li, T., Xu, M., Chen, X., Zhao, Y., Han, J., Piao, Y., et al. (2021) · eLife · doi:10.7554/elife.66222 · Cited by 30
“IL-18 is an immunoregulatory cytokine with anti-cancer effect in many types of cancers (Coughlin et al., 1998; Nishio et al., 2008; Salcedo et al., 2010; Zaki et al., 2010).”
BackgroundImplications of Protein Post-Translational Modifications in IBD
Ehrentraut, S., & Colgan, S. P. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22859 · Cited by 29
NLRC4, inflammation and colorectal cancer (Review)
Tong, G., Shen, Y., Li, H., Qian, H., & Tan, Z. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5687 · Cited by 28
Targeting inflammasomes as an immunotherapeutic strategy for cancer
Huang, L., Chen, X., Liu, R., Nan, D., Bao, W., Yang, L., Dai, X., Tang, J., Zhang, H., & Lu, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06665-2 · Cited by 28
“Increasing IL-18 can prevent colitis associated tumors in IL18 − / − , NLRP3 − / − and Caspase 1 − / − mice [113].”
Zeng, Q., Fu, J. L., Korrer, M. J., Gorbounov, M., Murray, P. J., Pardoll, D., Masica, D. L., & Kim, Y. J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0543 · Cited by 28
“In one colorectal metastasis model, the inflammasome complex was found to suppress metastasis via NK cell activity (45), and others showed that NLRP3 signaling in hematopoietic compartment can be protective against tumorigenesis through bone marrow chimera studies (31, 33).”
BackgroundLentinan triggers oxidative stress-mediated anti-inflammatory responses in lung cancer cells
Li, M., Du, X., Yuan, Z. J., Cheng, M., Dong, P., & Bai, Y. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04293-0 · Cited by 28
“NLRP3 null mice showed elevated invasion of colon cancer [4].”
BackgroundGao, M., Zhang, P., Huang, L., Shao, H., Duan, S., Li, C., Zhang, Q., Wang, W. T., Wu, Y., Wang, J., et al. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.109687 · Cited by 27
Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients?
Elgohary, S., Elkhodiry, A. A., Amin, N. S., Stein, U., & Tayebi, H. M. E. (2021) · Cells · doi:10.3390/cells10020302 · Cited by 27
Li, L., Xu, T., & Qi, X. (2024) · Immunological Reviews · doi:10.1111/imr.13417 · Cited by 27
“…recombinant IL-18 to mice with inflammasome deficiency with AOM and DSS reduces intestinal inflammation and tumor burden, highlighting the protective role of IL-18 in inflammation-mediated CRC. 160,161 Mature IL-18 is essential for enhancing IFN-γ production and the cytotoxicity of NK and T cells.”
Nod-Like Receptors: Key Molecular Switches in the Conundrum of Cancer
Kent, A., & Blander, J. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00185 · Cited by 27
“The IL-18 cytokine, cleaved into its biologically active form by activated caspase-1, has emerged as a key cytokine downstream of inflammasome activation that enables epithelial repair after damage, but also prevents cancer progression through its induction of the tumor suppressors STAT1 and IFN-γ (18).”
BackgroundBacterial Sphingolipids Exacerbate Colitis by Inhibiting ILC3-derived IL-22 Production
Bao, B., Wang, Y., Boudreau, P., Song, X., Wu, M., Chen, X., Patik, I., Tang, Y., Ouahed, J., Ringel, A., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.04.007 · Cited by 26
Li, G. Q., Gao, S. X., Wang, F. H., Kang, L., Tang, Z. Y., & Xiao, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115019 · Cited by 26
Pyroptosis: a new insight into intestinal inflammation and cancer
Chao, L., Zhang, W., Feng, Y., Gao, P., & Ma, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1364911 · Cited by 26
Inoue, N., Li, W., Fujimoto, Y., Matsushita, Y., Katagiri, T., Okamura, H., & Miyoshi, Y. (2019) · Anticancer Research · doi:10.21873/anticanres.13691 · Cited by 26
Biliverdin and bilirubin sulfonate inhibit monosodium urate induced sterile inflammation in the rat
Shiels, R. G., Hewage, W., Pennell, E. N., Vidimce, J., Grant, G. D., Pearson, A., Wagner, K., Morgan, M., & Bulmer, A. C. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105546 · Cited by 26
Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
Looi, C.-K., Hii, L., Chung, F. F., Mai, C., Lim, W., & Leong, C. (2021) · Cancers · doi:10.3390/cancers13081786 · Cited by 26
Dagenais, M., Dupaul-Chicoine, J., Champagne, C., Skeldon, A. M., Morizot, A., & Saleh, M. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.46 · Cited by 26
“In the absence of inflammasome-induced repair, micewith targeted deletion ofCasp1 or Il18, among others, were highly susceptible to AOM–DSS tumorigenesis.(44,47,59) Our results demonstrating that IL-18BP administration toBirc3 / mice abrogated any residual IEC proliferation following AOM injection and one cycle of DSS…”
New prospects of cancer therapy based on pyroptosis and pyroptosis inducers
Chen, Q., Sun, Y., Wang, S., & Xu, J. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01906-5 · Cited by 25
“Salaro et al. [83 ] achieved NLRP3 overex - pression in CLL through plasmid transfection.”
NLRP3: A Promising Therapeutic Target for Inflammatory Bowel Disease
Zhang, J., Zeng, S., Wang, P., Chen, Y., & Zeng, C. (2023) · Current Drug Targets · doi:10.2174/0113894501255960231101105113 · Cited by 25
The indole compound MA-35 attenuates tumorigenesis in an inflammation-induced colon cancer model
Kanehara, K., Ohnuma, S., Kanazawa, Y., Sato, K., Kokubo, S., Suzuki, H., Karasawa, H., Suzuki, T., Suzuki, C., Naitoh, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48974-9 · Cited by 25
Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis
Chen, J., Singh, N., Ye, X., Theune, E. V., & Wang, K. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00796-2 · Cited by 24
López-Pérez, D., Prados-Lopez, B., Gálvez, J., León, J., & Carazo, Á. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116098 · Cited by 24
“Furthermore, in macrophages and epithelial cells, these DAMPs and PAMPs promote the activation of the inflammasome pathway, which releases activated IL-18 [49].”
BackgroundNi, G., Yang, X., Li, J., Wu, X., Liu, Y., Li, H., Chen, S., Fogarty, C. E., Frazer, I. H., Chen, G., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1335 · Cited by 25
“The upregulation of Nlrp3 was shown to induce Stat1 phosphorylation through IFN-c and thus promote an antitumorigenic environment.(94) The proteomic analysis identified Stat1 only upregulated in the caerin group with significance, and it appeared as the node with the highest degree of interactions with other upregulat…”
BackgroundInflammatory Bowel Diseases and Inflammasome
Kim, J. M. (2011) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2011.58.6.300 · Cited by 24
“또한 IL-18은 종양성장과 혈관형성을 억 제하고,(99-101) 손상된 상피세포층의 회복을 촉진시킨다.(75,78,96) 그리고 DSS를 투여한 NLRP3 casp1 마우스의 대장과(74,75) AOM/DSS를 처리한 NLRP3 casp1 마우스의 대장에서(77,96) IL-18의 발현이 유의하게 감소하였다.”
InfluentialMetabolic underpinnings of cancer-related fatigue
Zhang, X., & Perry, R. J. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00378.2023 · Cited by 23
Barsoumian, H. B., He, K., Hsu, E. Y., Bertolet, G., Sezen, D., Hu, Y. Y., Riad, T. S., Cortez, M. A., & Welsh, J. W. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03471-x · Cited by 23
Mechanisms and effects of NLRP3 in digestive cancers
Si, Y., Liu, L., & Fan, Z. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01783-6 · Cited by 23
“Thus it has a protective effect against colitis-related tumorigenesis [13].”
BackgroundImmunotherapeutic Approach for Better Management of Cancer - Role of IL-18
Kuppala, M. B., Syed, S. B., Bandaru, S., Varre, S., Jyothy, A., & Mundulru, H. P. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.11.5353 · Cited by 23
“IL-18 production downstream of the Nlrp3 inflammasome is critically involved in protection against colorectal tumorigenesis (Zaki et al., 2010).”
BackgroundThe innate immune signaling in cancer and cardiometabolic diseases: Friends or foes?
Wang, W., Zhang, Y., Yang, L., & Li, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.06.004 · Cited by 22
Gasdermin D represses inflammation-induced colon cancer development by regulating apoptosis
Tanaka, S., Orita, H., Kataoka, T., Miyazaki, M., Saeki, H., Wada, R., Brock, M. V., Fukunaga, T., Amano, T., & Shiroishi, T. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad005 · Cited by 22
Inflammasomes and intestinal tumorigenesis
Zaki, H., Lamkanfi, M., & Kanneganti, T. (2011) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2011.11.003 · Cited by 21
“were restored upon stimulation with either IFN-γ or IL-18 [32].”
BackgroundInfluentialSelf-citationReview: New Anti-Cytokines for IBD: What is in the Pipeline?
Scharl, M. M., Vavricka, S. R., & Rogler, G. (2013) · Current Drug Targets · doi:10.2174/13894501113149990159 · Cited by 22
Inflammation suppresses DLG2 expression decreasing inflammasome formation
Keane, S., Herring, M., Rolny, P., Wettergren, Y., & Ejeskär, K. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04029-7 · Cited by 21
“2016), whilst IL-18 contributes to inflammasome mediated protection against tumorigenesis in colitis patients (Zaki et al. 2010).”
BackgroundHou, J., Li, T., Hsu, J.-M., Zhang, X., & Hung, M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101833 · Cited by 21
Zhang, Y., Chen, X., Fu, Q., Wang, F., Zhou, X., Xiang, J., He, N., Hu, Z., & Jin, X. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02384-y · Cited by 21
The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
Hreich, S. J. D., Hofman, P. M., & Vouret‐Craviari, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119235 · Cited by 21
“Indeed, there is an absence of the components of the NLRP3 inflammasome, IL-18 exacerbated cancer progression [97] and inflammatory markers [98].”
BackgroundMicroplastics as environmental modifiers of lung disease
Epeslidou, E., Scott, J. S., de Klein, B., Cudia, J. T., Melgert, B. N., & Preković, S. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00353-w · Cited by 20
“Markedly, both asthma and COPD display elevated expression of IL-19 and BCL2L15 genes upon microplastic exposure, linking these pollutants to a shared axis of Th2-associated in fl ammation and potentially carcinogenic signaling (Papli ń ska-Goryca et al, 2025).”
InfluentialPrognostic Role of Inflammasome Components in Human Colorectal Cancer
Domblides, C., Soubeyran, I., Lartigue, L., Mahouche, I., Lefort, F., Velasco, V., Barnetche, T., Blanco, P., Déchanet‐Merville, J., & Faustin, B. (2020) · Cancers · doi:10.3390/cancers12123500 · Cited by 20
“Indeed, in IL-18-/- mice, as in our cohort, a lower infiltration of immune cells, leading to lower interferon-γ production was observed [15].”
BackgroundLi, Z., Liu, Y., Lin, B., Yan, W., Yi, H., Wang, H., & Wei, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.925338 · Cited by 20
“There is increasing evidence suggesting the indispensable role of pyroptosis in innate immunity and antitumor effects (Zaki et al., 2010; Wang Q et al., 2020; Tsuchiya, 2021).”
BackgroundProtein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation
Yang, Y., Inatsuka, C., Gad, E. A., Disis, M. L., Standish, L. J., Pugh, N. D., Pasco, D. S., & Lu, H. (2013) · Innate Immunity · doi:10.1177/1753425913513814 · Cited by 20
“Furthermore, inflammasome activation and the release of IL-1b and IL-18 have been shown to have tumor protection effects.(7,8) Protein-bound polysaccharide-K (PSK) is a partially purified hot water extract of Trametes (Coriolus) versicolor strain CM-101, and is one of the most widely used mushroom extracts.”
Yang, X., Cao, N., Chen, L., Liu, L., Zhang, M., & Cao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714383 · Cited by 18
Inflammatory responses during trichomoniasis: The role of Toll‐like receptors and inflammasomes
Jafarzadeh, A., Nemati, M., Salarkia, E., Yadav, S., Aminizadeh, N., Jafarzadeh, S., & Yadav, M. C. (2023) · Parasite Immunology · doi:10.1111/pim.13000 · Cited by 17
“The NLRP3 inflammasome-mediated IL-18 production leads to IFN-γ production and STAT-1 activation, which confer protection against colorectal cancer progression.(112) Furthermore, IL-18 activate natural killer (NK) cells which induce apoptosis in cancerous cells through a FasL-dependent manner.”
BackgroundRegulation of NLRP3/TRIM family signaling in gut inflammation and colorectal cancer
Mohapatra, B. S., Lavudi, K., Kokkanti, R. R., & Patnaik, S. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189271 · Cited by 17
Holding the inflammatory system in check: NLRs keep it cool
Jha, S., & Ting, J. P.-Y. (2015) · F1000Prime Reports · doi:10.12703/p7-15 · Cited by 17
“Treatment of caspase-1 mice with recombinant IL-18 led to a reduction in disease, demonstrating a crucial role of IL-18 in protection against CAC development [84,85].”
BackgroundThe Role of Inflammasome-Associated Innate Immune Receptors in Cancer
Dawson, R., & Jenkins, B. J. (2024) · Immune Network · doi:10.4110/in.2024.24.e38 · Cited by 16
“…studies using the AOM/DSS-induced CAC model have reported that NLRP3 deficiency in mice exacerbated colonic inflammation-associated tumourigenesis—similar to observations in ASC-deficient mice—leading to the notion that the NLRP3 inflammasome (via IL-18) acts as a tumour suppressor in CRC (99,100).”
BackgroundResultLiu, L., Chen, W., Li, Y., Fu, P., Cao, Y., Li, Z., Xiong, J., & Jie, Z. (2022) · Journal of Oncology · doi:10.1155/2022/2035808 · Cited by 16
Ganesan, R., & Suk, K. T. (2022) · Livers · doi:10.3390/livers2030012 · Cited by 16
Awwad, S. F., Assaf, R., Emam, A. A., Fouad, A., Arafa, L. F., & El-Hanafy, A. A. (2023) · Medical Oncology · doi:10.1007/s12032-022-01945-z · Cited by 16
Iida, T., Hirayama, D., Minami, N., Matsuura, M., Wagatsuma, K., Kawakami, K., Nagaishi, K., Nojima, M., Ikeuchi, H., Hirota, S., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.10.003 · Cited by 16
Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
de Jesus, J. D. C. R., Murari, A. S. D. P., Radloff, K., de Moraes, R. C. M., Figuerêdo, R. G., Pessoa, A. F. M., Neto, J. C. R., de Matos‐Neto, E. M., de Alcântara, P. S. M., Tokeshi, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.729182 · Cited by 15
“Deficiency in the genes nlrp3 and caspase-1 is related with a strong inflammatory response and destruction of the epithelial barrier, with consequent dysplasia, tumorigenesis, and greater tumor burden in the colon (70, 71).”
BackgroundDeswaerte, V., Ruwanpura, S. M., & Jenkins, B. J. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.09.023 · Cited by 15
Damage control: Management of cellular stress by the NLRP 3 inflammasome
Haasken, S., & Sutterwala, F. S. (2013) · European Journal of Immunology · doi:10.1002/eji.201343848 · Cited by 16
The Role and Therapeutic Potential of Pyroptosis in Colorectal Cancer: A Review
Fang, Q. Z., Xu, Y., Tan, X., Wu, X., Li, S., Yuan, J., Chen, X., Huang, Q., Fu, K., & Xiao, S. (2024) · Biomolecules · doi:10.3390/biom14070874 · Cited by 14
“Pyroptosis takes part in most aspects of the tumorigenesis and development of CRC [118–120].”
BackgroundSignal‐transducing innate receptors in tumor immunity
Hangai, S., Kimura, Y., Taniguchi, T., & Yanai, H. (2021) · Cancer Science · doi:10.1111/cas.14848 · Cited by 14
Chen, J., Chen, S., Li, B., Zhou, S., & Han, L. (2022) · Cancer Medicine · doi:10.1002/cam4.5247 · Cited by 14
Jing, X., Yun, Y., Ji, X., Yang, E., & Li, P. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s424326 · Cited by 14
“Also, knock out of NLRP3, ASC, and Caspase-1 promoted tumor growth in colorectal cancer mice model, indicating that dysfunction of NLRP3 inflammasome increased tumor burden.(26) In addition, according to Yuan et al, Cucurbitacin B can directly activate the NLRP3 inflammasome through binding to Toll-like receptor 4, an…”
BackgroundInflammasomes in Intestinal Disease: Mechanisms of Activation and Therapeutic Strategies
Scalavino, V., Piccinno, E., Giannelli, G., & Serino, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313058 · Cited by 13
Molecular Mechanism of NLRP3 Inflammasome in Inflammatory Diseases and Tumors
Gong, L., Zhou, H., Zhao, Q., Xu, N., Huang, F., Su, L., & Li, W. (2025) · Immunity Inflammation and Disease · doi:10.1002/iid3.70213 · Cited by 13
Zhou, Z., Wei, J., Lu, B. F., Jiang, W., Bao, Y., Luo, L., & Wang, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.763807 · Cited by 13
The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?
Spallotta, F., & Illi, B. (2024) · Biomedicines · doi:10.3390/biomedicines12112631 · Cited by 13
“HDACi have been”
Chemotherapy ± Cetuximab Modulates Peripheral Immune Responses in Metastatic Colorectal Cancer
Xynos, I. D., Karadima, M. L., Voutsas, I. F., Amptoulach, S., Skopelitis, E. E., Kosmas, C., Gritzapis, A. D., & Tsavaris, N. B. (2013) · Oncology · doi:10.1159/000343282 · Cited by 13
Prossomariti, A., Sokol, H., & Ricciardiello, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01039 · Cited by 13
“Moreover, Nlrp12 deficiency significantly increased the colonic inflammation and tumorigenesis susceptibility through an increased production of pro-inflammatory cytokines and colonic activation of NF-kB, Erk, and Stat3 (34).”
BackgroundDjouina, M., Pichavant, M., Waxin, C., Dehaut, A., Loison, S., Driencourt, E., DEBORGHER, A., BALESDENT, C., Launay, D., Dubuquoy, L., et al. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.127794 · Cited by 12
Self-citationWest, A. J., Deswaerte, V., West, A. C., Gearing, L. J., Tan, P. B. O., & Jenkins, B. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.830350 · Cited by 12
“For instance, Nlrp3-/- mice are more susceptible to chemicalinduced colitis-associated colon cancer (CAC), whereas conversely, Nlrp3-/- mice are protected against tumor initiation and progression in a chemical-induced skin carcinogenesis model (27, 28).”
InfluentialXu, Z., Zhao, Y., Zhang, Y., Liu, X., Song, L., Chen, M., Xiao, G., Ma, X., & Shi, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1387647 · Cited by 12
Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome
Far, N. P., Varnousafaderani, M. H., Faghihkhorasani, F., Etemad, S., Abdulwahid, A. R. R., Bakhtiarinia, N., Mousaei, A., Dortaj, E., Karimi, S., Ebrahimi, N., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17352 · Cited by 13
“Moreover, NLRP3 inflammasome deficiency is accompanied by an increased tumour burden in colorectal cancer (Zaki et al., 2010).”
Innate Immune Stimulation in Cancer Therapy
Duewell, P., Heidegger, S. M., & Kobold, S. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.12.002 · Cited by 12
Gao, Y., Zhang, X., Li, Y., Gao, J., Liu, S., Cai, H., & Zhang, J. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05074-6 · Cited by 12
ASC deficiency suppresses proliferation and prevents medulloblastoma incidence
Knight, E. R. W., Patel, E., Flowers, C., Crowther, A., Ting, J. P. ‐., Miller, C. R., Gershon, T. R., & Deshmukh, M. (2014) · Oncogene · doi:10.1038/onc.2013.577 · Cited by 12
Using Cytometry for Investigation of Purinergic Signaling in Tumor‐Associated Macrophages
Arnaud-Sampaio, V. F., Rabelo, I. L. A., Bento, C. A., Glaser, T., Silva, J. B., Coutinho‐Silva, R., Ulrich, H., & Lameu, C. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24035 · Cited by 12
“IL-18 production downstream of the Nlrp3 Inflammasome confers protection against colorectal tumor formation.”
BackgroundInfluentialNiu, J., Wen, Y., Zhang, F., Li, S., Miao, J., Liang, H., Bai, X., Zeng, Z., Guo, X., & Miao, Y. (2024) · The FASEB Journal · doi:10.1096/fj.202401185r · Cited by 11
Zeng, D., Wang, X., Zhang, S., Ao, Z., Huang, Q., & Cao, L. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.903271 · Cited by 11
Pan, J.-M., Liang, Y., Zhu, K.-C., Guo, H., Liu, B.-S., Zhang, N., & Zhang, D. (2023) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2023.105123 · Cited by 11
Stergiou, I. Ε., Tsironis, C., Papadakos, S. P., Tsitsilonis, O., Dimopoulos, M. A., & Theocharis, S. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042369 · Cited by 11
“Despite these reports supporting the pro-tumorigenic role of the NLRP3 inflammasome, we should note that research has additionally indicated a tumor-protective role in certain cancers, such as colitis-associated cancer [16], colorectal cancer [17], hepatocellular carcinoma [18], and melanoma [19].”
BackgroundThe Role of Hemophilus influenzae Infection and Its Relationship With Colorectal Cancer
Fortoul, M. C., Kim, E., Ardeljan, A., Frankel, L. R., Takabe, K., & Rashid, O. M. (2023) · World Journal of Oncology · doi:10.14740/wjon1584 · Cited by 11
“CCI: Charlson Comorbidity Index; COPD: chronic obstructive pulmonary disease; CRC: colorectal cancer; GLA: gutlung axis; IBD: inflammatory bowel disease; MPL: 3-O-desacyl-4-monophosphoryl lipid A; NLRP3: nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3; NTHi: non-typeable H. influen…”
BackgroundHost–Viral Interactions in the Pathogenesis of Ulcerative Colitis
Bruland, T., Østvik, A. E., Sandvik, A. K., & Hansen, M. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910851 · Cited by 10
“Others have found an increase in IL28A expression (one of the type III IFNs) in the colonic epithelium of patients with UC where it induces the phosphorylation of STAT1, leading to epithelial cell proliferation in patient-derived organoids [105].”
BackgroundInfluential
Metadata
- Authors
- Zaki, M. H., Vogel, P., Body-Malapel, M., Lamkanfi, M., & Kanneganti, T.-D.
- Affiliations
- Department of Immunology , Memphis, TN 38105
- St. Jude Children's Research Hospital (US)
- Department of Physiopathology of Inflammatory Bowel Diseases, INSERM Unité 995 , Lille ,
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Kanneganti, Thirumala-Devi
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 185
- Issue
- 8
- Pages
- 4912-4920
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3104023
- OpenAlex
- W1954263225
- Cited by
- 411
- References
- 62
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 39 · 2023: 26 · 2022: 42 · 2021: 43 · 2020: 20 · 2019: 30 · 2018: 26 · 2017: 24 · 2016: 22 · 2015: 26 · 2014: 18 · 2013: 25 · 2012: 20
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Yale University
- St. Jude Children's Research Hospital
- American Lebanese Syrian Associated Charities (AR056296, CA 21765)
- Vlaamse regering
- National Institutes of Health (CA21765))
- Takeda Oncology
- National Cancer Institute (2 P30 CA21765, P30CA021765)
- National Institute of Allergy and Infectious Diseases (AI088177, R21AI088177)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR056296, AR-056296)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-18, NLRP3 inflammasome, colorectal cancer, colorectal carcinogenesis, caspase-1, interferon-gamma, STAT1, chronic inflammation, azoxymethane/dextran sulfate sodium, tumor suppression
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cell Transformation, Neoplastic, Enzyme-Linked Immunosorbent Assay, Inflammation, Mice, Inbred C57BL, Blotting, Western, Colorectal Neoplasms, Cytokines, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Interleukin-18, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.